128 related articles for article (PubMed ID: 6314043)
21. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
Skopp G; Richter B; Pötsch L
Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
[TBL] [Abstract][Full Text] [Related]
22. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoids in plasma after passive inhalation of marijuana smoke.
Mason AP; Perez-Reyes M; McBay AJ; Foltz RL
JAMA; 1983 Jan; 249(4):475-6. PubMed ID: 6294352
[No Abstract] [Full Text] [Related]
25. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
26. Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis.
Lee MS; Lanes A; Ginsburg ES; Fox JH
J Assist Reprod Genet; 2020 Jun; 37(6):1497-1504. PubMed ID: 32356125
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.
Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924
[No Abstract] [Full Text] [Related]
28. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
Uhl M; Sachs H
Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoids in oral fluid following passive exposure to marijuana smoke.
Moore C; Coulter C; Uges D; Tuyay J; van der Linde S; van Leeuwen A; Garnier M; Orbita J
Forensic Sci Int; 2011 Oct; 212(1-3):227-30. PubMed ID: 21763088
[TBL] [Abstract][Full Text] [Related]
30. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
[TBL] [Abstract][Full Text] [Related]
31. The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Sørensen LK; Hasselstrøm JB
Drug Test Anal; 2018 Feb; 10(2):301-309. PubMed ID: 28570781
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
33. Marijuana poisoning.
Fitzgerald KT; Bronstein AC; Newquist KL
Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
[TBL] [Abstract][Full Text] [Related]
34. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
35. Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma.
Johnson JR; Jennison TA; Peat MA; Foltz RL
J Anal Toxicol; 1984; 8(5):202-4. PubMed ID: 6094914
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.
Hanson VW; Buonarati MH; Baselt RC; Wade NA; Yep C; Biasotti AA; Reeve VC; Wong AS; Orbanowsky MW
J Anal Toxicol; 1983; 7(2):96-102. PubMed ID: 6304423
[TBL] [Abstract][Full Text] [Related]
37. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.
Cone EJ; Huestis MA
Ther Drug Monit; 1993 Dec; 15(6):527-32. PubMed ID: 8122288
[TBL] [Abstract][Full Text] [Related]
38. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
Moody DE; Rittenhouse LF; Monti KM
J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
[TBL] [Abstract][Full Text] [Related]
39. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
[TBL] [Abstract][Full Text] [Related]
40. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
Fraser AD; Worth D
Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
